Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia
Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metab...
Saved in:
Published in | Molecular cancer Vol. 9; no. 1; p. 284 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
28.10.2010
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL. In this study we have further explored the relationship between MLL status and GC sensitivity.
Negative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL-rearrangements suggested that this relationship represented expression of wild-type MLL. Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL-rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis.
The data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL-translocations. |
---|---|
AbstractList | Abstract Background: Rearrangement of the mixed-lineage leukemia gene (MLL ) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL . In this study we have further explored the relationship between MLL status and GC sensitivity. Results: Negative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL -rearrangements suggested that this relationship represented expression of wild-type MLL . Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL -rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis. Conclusions: The data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL -translocations. Abstract Background Rearrangement of the mixed-lineage leukemia gene ( MLL ) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL . In this study we have further explored the relationship between MLL status and GC sensitivity. Results Negative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL -rearrangements suggested that this relationship represented expression of wild-type MLL . Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL -rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis. Conclusions The data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL -translocations. Background Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL. In this study we have further explored the relationship between MLL status and GC sensitivity. Results Negative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL-rearrangements suggested that this relationship represented expression of wild-type MLL. Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL-rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis. Conclusions The data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL-translocations. Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL. In this study we have further explored the relationship between MLL status and GC sensitivity. Negative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL-rearrangements suggested that this relationship represented expression of wild-type MLL. Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL-rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis. The data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL-translocations. BACKGROUNDRearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL. In this study we have further explored the relationship between MLL status and GC sensitivity. RESULTSNegative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL-rearrangements suggested that this relationship represented expression of wild-type MLL. Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL-rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis. CONCLUSIONSThe data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL-translocations. Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and resistance to glucocorticoids (GCs). We have recently observed that GC resistance in T-ALL cell lines is associated with a proliferative metabolism and reduced expression of MLL. In this study we have further explored the relationship between MLL status and GC sensitivity. Negative correlation of MLL expression with GC resistance in 15 T-ALL cell lines was confirmed by quantitative RT-PCR. The absence of MLL-rearrangements suggested that this relationship represented expression of wild-type MLL. Analysis of MLL expression patterns revealed a negative relationship with cellular metabolism, proliferation and anti-apoptotic transcriptional networks. In silico analysis of published data demonstrated that reduced levels of MLL mRNA are associated with relapse and prednisolone resistance in T-ALL patients and adverse clinical outcome in children with MLL-rearranged ALL. RNAi knockdown of MLL expression in T-ALL cell lines significantly increased resistance to dexamethasone and gamma irradiation indicating an important role for wild-type MLL in the control of cellular apoptosis. The data suggests that reduced expression of wild-type MLL can contribute to GC resistance in ALL patients both with and without MLL-translocations. |
ArticleNumber | 284 |
Audience | Academic |
Author | Heng, Jasmin Y S Samuels, Amy L Ford, Jette Kees, Ursula R Palmer, Misty-Lee Firth, Martin J Rampellini, Janelle L Beesley, Alex H |
AuthorAffiliation | 2 Division of Biostatistics and Genetic Epidemiology, Telethon Institute for Child Health Research, University of Western Australia Centre for Child Health Research, Perth, Australia 3 Curtin University of Technology School of Pharmacy, Perth, Western Australia 1 Division of Children's Leukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia Centre for Child Health Research, Perth, Australia |
AuthorAffiliation_xml | – name: 1 Division of Children's Leukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia Centre for Child Health Research, Perth, Australia – name: 2 Division of Biostatistics and Genetic Epidemiology, Telethon Institute for Child Health Research, University of Western Australia Centre for Child Health Research, Perth, Australia – name: 3 Curtin University of Technology School of Pharmacy, Perth, Western Australia |
Author_xml | – sequence: 1 givenname: Alex H surname: Beesley fullname: Beesley, Alex H organization: Division of Children's Leukaemia and Cancer Research, Telethon Institute for Child Health Research, University of Western Australia Centre for Child Health Research, Perth, Australia – sequence: 2 givenname: Janelle L surname: Rampellini fullname: Rampellini, Janelle L – sequence: 3 givenname: Misty-Lee surname: Palmer fullname: Palmer, Misty-Lee – sequence: 4 givenname: Jasmin Y S surname: Heng fullname: Heng, Jasmin Y S – sequence: 5 givenname: Amy L surname: Samuels fullname: Samuels, Amy L – sequence: 6 givenname: Martin J surname: Firth fullname: Firth, Martin J – sequence: 7 givenname: Jette surname: Ford fullname: Ford, Jette – sequence: 8 givenname: Ursula R surname: Kees fullname: Kees, Ursula R |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20979663$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkktv1DAUhSNURB-wZocsWLBK61cce4M0lNdIA2xgbTnO9dQlsYc4KZoF_x2HKaMOKkJe2Lo-_nR9zj0tjkIMUBRPCT4nRIoLwmtR8krJUpVU8gfFyb5ydOd8XJymdI0xqWXNHxXHFKtaCcFOip_L4LoJggUUHfrhu7YctxtAH1crFANad5ONNg6jt9G3KEFIfvQ3ftwiE1o0QNrEkACNEb35tChb05s1IB_QBlpvxsFbZOw0Auq2_eYqNp1JGYU6mL5B783j4qEzXYInt_tZ8fXd2y-XH8rV5_fLy8WqbARnY2nASCeFwExSIi1mlrWU8ZYQ1ZgKc6IA14Qb54RllagqgpWRkvDWEVc7yc6K5Y7bRnOtN4PvzbDV0Xj9uxCHtTbzHzvQxoJTTQOKVIwLLCSmtHKOOsMElabOrFc71mZqemgthHEw3QH08Cb4K72ON5oqWSvJMuD1DtD4-A_A4Y2NvZ6j1HOUWukcdIa8vO1iiN8nSKPufbLQdSZAnJKWgquqUkr-X4klF4RwmpXP_1Jex2kIORitsgtcZVuz6MVOtDbZLR9czD3aGakXlFMueVXNJp3fo8qrzbHbPMPO5_rBg4vdAzvElAZwez8I1vOo3-PAs7s57PV_Zpv9Anre-yI |
CitedBy_id | crossref_primary_10_1038_bcj_2014_52 crossref_primary_10_1111_cas_14892 crossref_primary_10_1097_MPH_0000000000002697 crossref_primary_10_1158_0008_5472_CAN_12_3852 crossref_primary_10_18632_oncotarget_11233 crossref_primary_10_1111_bjh_13120 |
Cites_doi | 10.1182/blood-2005-07-3011 10.1111/j.1365-2141.2005.05785.x 10.1016/j.semcancer.2005.01.007 10.1182/blood-2005-11-4728 10.1096/fj.00-0327com 10.1002/gcc.20338 10.1038/sj.bjc.6603447 10.1182/blood-2005-07-2853 10.1016/j.ejca.2005.02.026 10.1182/blood-2003-01-0338 10.1182/blood.V86.10.3861.bloodjournal86103861 10.1074/jbc.M412237200 10.1182/blood-2005-01-0204 10.1038/sj.leu.2404150 10.1073/pnas.0506580102 10.1056/NEJMoa033513 10.1016/j.leukres.2008.08.007 10.1111/j.1365-2141.2005.05433.x 10.1038/emboj.2009.258 10.1182/blood.V86.5.1881.bloodjournal8651881 10.1200/JCO.1998.16.4.1270 10.1038/sj.leu.2402491 10.1182/blood.V94.1.283.413k23_283_290 10.1038/sj.leu.2401129 10.1186/1471-2407-9-147 10.1038/ng1651 10.1111/j.1365-2141.2005.05909.x 10.1182/blood-2008-12-191619 10.1038/sj.leu.2404031 10.1038/nrc2253 10.1111/j.1365-2141.2007.06527.x 10.1038/nature09350 10.1038/sj.leu.2403253 10.1186/1471-2164-6-59 10.1038/sj.bjc.6605072 10.1080/10428190701606826 10.1126/science.1160809 10.1158/0008-5472.CAN-05-3826 10.1111/j.1365-2141.2007.06966.x 10.1038/sj.leu.2402883 10.1073/pnas.1132115100 10.1038/sj.onc.1203145 10.1101/gad.1574507 10.1007/s12185-007-0009-8 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2010 BioMed Central Ltd. 2010 Beesley et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2010 Beesley et al; licensee BioMed Central Ltd. 2010 Beesley et al; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2010 BioMed Central Ltd. – notice: 2010 Beesley et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2010 Beesley et al; licensee BioMed Central Ltd. 2010 Beesley et al; licensee BioMed Central Ltd. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 7TM 5PM DOA |
DOI | 10.1186/1476-4598-9-284 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Nucleic Acids Abstracts PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic Nucleic Acids Abstracts |
DatabaseTitleList | Publicly Available Content Database CrossRef Nucleic Acids Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1476-4598 |
EndPage | 284 |
ExternalDocumentID | oai_doaj_org_article_acef9bbe9153460680225ff2fa3628a7 oai_biomedcentral_com_1476_4598_9_284 2503541361 A242484557 10_1186_1476_4598_9_284 20979663 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Australia |
GeographicLocations_xml | – name: Australia |
GroupedDBID | --- -A0 0R~ 123 29M 2VQ 2WC 3V. 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACMJI ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EJD EMB EMK EMOBN ESX F5P FRP FYUFA GROUPED_DOAJ GX1 H13 HH5 HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO PZZ RBZ RIG RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX CITATION ABVAZ AFGXO AFNRJ 7TO 7XB 8FK AZQEC DWQXO H94 K9. PQEST PQUKI PRINS 7X8 7TM 5PM |
ID | FETCH-LOGICAL-b643t-aea8f866038218c03c3d234d119ba50419e0714aff6c35655109a8814df1f7f83 |
IEDL.DBID | RPM |
ISSN | 1476-4598 |
IngestDate | Tue Oct 22 15:04:34 EDT 2024 Tue Sep 17 21:16:41 EDT 2024 Wed May 22 07:10:31 EDT 2024 Sat Oct 26 00:17:14 EDT 2024 Fri Oct 25 03:59:07 EDT 2024 Thu Oct 10 15:51:18 EDT 2024 Thu Feb 22 23:51:12 EST 2024 Fri Feb 02 04:32:49 EST 2024 Thu Sep 12 20:00:15 EDT 2024 Sat Sep 28 07:59:08 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b643t-aea8f866038218c03c3d234d119ba50419e0714aff6c35655109a8814df1f7f83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987983/ |
PMID | 20979663 |
PQID | 902249109 |
PQPubID | 42702 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_acef9bbe9153460680225ff2fa3628a7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2987983 biomedcentral_primary_oai_biomedcentral_com_1476_4598_9_284 proquest_miscellaneous_864955998 proquest_miscellaneous_808461142 proquest_journals_902249109 gale_infotracmisc_A242484557 gale_infotracacademiconefile_A242484557 crossref_primary_10_1186_1476_4598_9_284 pubmed_primary_20979663 |
PublicationCentury | 2000 |
PublicationDate | 2010-10-28 |
PublicationDateYYYYMMDD | 2010-10-28 |
PublicationDate_xml | – month: 10 year: 2010 text: 2010-10-28 day: 28 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Molecular cancer |
PublicationTitleAlternate | Mol Cancer |
PublicationYear | 2010 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 15813846 - Br J Haematol. 2005 Apr;129(2):189-98 7579354 - Blood. 1995 Nov 15;86(10):3861-8 11259387 - FASEB J. 2001 Mar;15(3):693-9 18218047 - Br J Haematol. 2008 Mar;140(6):716-9 10602495 - Oncogene. 1999 Dec 2;18(51):7387-8 20818375 - Nature. 2010 Sep 16;467(7313):343-6 18789525 - Leuk Res. 2009 Feb;33(2):321-5 19436302 - Br J Cancer. 2009 Jun 16;100(12):1926-36 9552025 - J Clin Oncol. 1998 Apr;16(4):1270-8 17117183 - Br J Cancer. 2006 Dec 4;95(11):1537-44 17917979 - Leuk Lymphoma. 2007 Oct;48(10):2083-6 9737681 - Leukemia. 1998 Sep;12(9):1344-8 16293608 - Blood. 2006 Mar 1;107(5):2061-9 16688745 - Genes Chromosomes Cancer. 2006 Aug;45(8):754-60 10381524 - Blood. 1999 Jul 1;94(1):283-90 16651409 - Cancer Res. 2006 May 1;66(9):4591-601 11986959 - Leukemia. 2002 May;16(5):949-51 14712291 - Leukemia. 2004 Mar;18(3):521-9 16200064 - Nat Genet. 2005 Nov;37(11):1289-95 16307022 - Leukemia. 2006 Jan;20(1):179-82 17908926 - Genes Dev. 2007 Oct 1;21(19):2385-98 15869873 - Eur J Cancer. 2005 Jun;41(9):1300-3 15295046 - N Engl J Med. 2004 Aug 5;351(6):533-42 16511515 - Leukemia. 2006 May;20(5):777-84 12782787 - Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7853-8 16445826 - Br J Haematol. 2006 Mar;132(5):539-51 19421859 - Apoptosis. 2009 Jun;14(6):821-8 12941810 - Cancer Res. 2003 Aug 15;63(16):4882-7 12682627 - Leukemia. 2003 Apr;17(4):700-6 19460998 - Science. 2009 May 22;324(5930):1029-33 7655016 - Blood. 1995 Sep 1;86(5):1881-6 17391490 - Br J Haematol. 2007 Apr;137(2):109-16 12730115 - Blood. 2003 Oct 15;102(8):2951-9 15826832 - Semin Cancer Biol. 2005 Jun;15(3):175-88 19763085 - EMBO J. 2009 Oct 21;28(20):3185-95 17957188 - Nat Rev Cancer. 2007 Nov;7(11):823-33 15774615 - Blood. 2005 Jul 1;106(1):345-52 15851483 - J Biol Chem. 2005 Jul 1;280(26):24315-21 16281934 - Br J Haematol. 2005 Nov;131(4):447-56 19749093 - Blood. 2009 Nov 5;114(19):4169-78 15854232 - BMC Genomics. 2005;6:59 16478880 - Blood. 2006 Jun 15;107(12):4663-5 16556894 - Blood. 2006 Jul 15;108(2):441-51 18224408 - Int J Hematol. 2008 Jan;87(1):10-8 19445675 - BMC Cancer. 2009;9:147 16199517 - Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 SP Whitman (798_CR41) 2005; 106 RA Dickins (798_CR20) 2005; 37 PB Dallas (798_CR19) 2005; 6 MG Vander Heiden (798_CR30) 2009; 324 AH Beesley (798_CR11) 2009; 100 E Klumper (798_CR26) 1995; 86 AH Beesley (798_CR14) 2005; 131 S Takeuchi (798_CR40) 1999; 18 SC Raimondi (798_CR39) 1995; 86 S Schmidt (798_CR35) 2006; 107 C Meyer (798_CR5) 2006; 20 A Kotani (798_CR37) 2009; 114 J Palle (798_CR7) 2005; 129 A Holleman (798_CR17) 2004; 351 RW Stam (798_CR2) 2006; 132 NL Ramakers-van Woerden (798_CR8) 2004; 18 JM Hilden (798_CR3) 2006; 108 M Tonko (798_CR28) 2001; 15 R Pieters (798_CR1) 1998; 12 AV Krivtsov (798_CR24) 2007; 7 AH Beesley (798_CR12) 2006; 95 M Eguchi (798_CR45) 2006; 45 A Daser (798_CR4) 2005; 15 H Liu (798_CR46) 2010; 467 D Wiederschain (798_CR44) 2005; 280 RW Stam (798_CR32) 2006; 20 J Nagayama (798_CR27) 2006; 107 MJ Henderson (798_CR6) 2008; 140 AH Beesley (798_CR13) 2007; 137 CH Pui (798_CR9) 2003; 17 C Ploner (798_CR10) 2009 GJ Kaspers (798_CR25) 2005; 41 NA Heerema (798_CR22) 1998; 16 NL Ramakers-van Woerden (798_CR33) 2002; 16 M Kubicka (798_CR43) 2007; 48 ME Ross (798_CR18) 2003; 102 JC Webb (798_CR38) 1999; 94 N Cerveira (798_CR42) 2009; 9 S Tsutsumi (798_CR16) 2003; 63 H Liu (798_CR29) 2007; 21 ER Lawlor (798_CR34) 2006; 66 Y Dou (798_CR23) 2008; 87 A Subramanian (798_CR15) 2005; 102 S Tyagi (798_CR31) 2009; 28 AH Beesley (798_CR21) 2009; 33 T Rozovskaia (798_CR36) 2003; 100 |
References_xml | – volume: 108 start-page: 441 year: 2006 ident: 798_CR3 publication-title: Blood doi: 10.1182/blood-2005-07-3011 contributor: fullname: JM Hilden – volume: 131 start-page: 447 year: 2005 ident: 798_CR14 publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2005.05785.x contributor: fullname: AH Beesley – volume: 15 start-page: 175 year: 2005 ident: 798_CR4 publication-title: Semin Cancer Biol doi: 10.1016/j.semcancer.2005.01.007 contributor: fullname: A Daser – volume: 107 start-page: 4663 year: 2006 ident: 798_CR27 publication-title: Blood doi: 10.1182/blood-2005-11-4728 contributor: fullname: J Nagayama – volume: 15 start-page: 693 year: 2001 ident: 798_CR28 publication-title: FASEB J doi: 10.1096/fj.00-0327com contributor: fullname: M Tonko – volume: 45 start-page: 754 year: 2006 ident: 798_CR45 publication-title: Genes Chromosomes Cancer doi: 10.1002/gcc.20338 contributor: fullname: M Eguchi – volume: 95 start-page: 1537 year: 2006 ident: 798_CR12 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6603447 contributor: fullname: AH Beesley – volume: 107 start-page: 2061 year: 2006 ident: 798_CR35 publication-title: Blood doi: 10.1182/blood-2005-07-2853 contributor: fullname: S Schmidt – volume: 41 start-page: 1300 year: 2005 ident: 798_CR25 publication-title: Eur J Cancer doi: 10.1016/j.ejca.2005.02.026 contributor: fullname: GJ Kaspers – volume: 102 start-page: 2951 year: 2003 ident: 798_CR18 publication-title: Blood doi: 10.1182/blood-2003-01-0338 contributor: fullname: ME Ross – volume: 86 start-page: 3861 year: 1995 ident: 798_CR26 publication-title: Blood doi: 10.1182/blood.V86.10.3861.bloodjournal86103861 contributor: fullname: E Klumper – volume: 280 start-page: 24315 year: 2005 ident: 798_CR44 publication-title: J Biol Chem doi: 10.1074/jbc.M412237200 contributor: fullname: D Wiederschain – volume: 106 start-page: 345 year: 2005 ident: 798_CR41 publication-title: Blood doi: 10.1182/blood-2005-01-0204 contributor: fullname: SP Whitman – volume: 20 start-page: 777 year: 2006 ident: 798_CR5 publication-title: Leukemia doi: 10.1038/sj.leu.2404150 contributor: fullname: C Meyer – volume: 102 start-page: 15545 year: 2005 ident: 798_CR15 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0506580102 contributor: fullname: A Subramanian – volume: 351 start-page: 533 year: 2004 ident: 798_CR17 publication-title: N Engl J Med doi: 10.1056/NEJMoa033513 contributor: fullname: A Holleman – volume: 33 start-page: 321 year: 2009 ident: 798_CR21 publication-title: Leuk Res doi: 10.1016/j.leukres.2008.08.007 contributor: fullname: AH Beesley – volume: 129 start-page: 189 year: 2005 ident: 798_CR7 publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2005.05433.x contributor: fullname: J Palle – volume: 28 start-page: 3185 year: 2009 ident: 798_CR31 publication-title: EMBO J doi: 10.1038/emboj.2009.258 contributor: fullname: S Tyagi – volume: 86 start-page: 1881 year: 1995 ident: 798_CR39 publication-title: Blood doi: 10.1182/blood.V86.5.1881.bloodjournal8651881 contributor: fullname: SC Raimondi – volume: 16 start-page: 1270 year: 1998 ident: 798_CR22 publication-title: J Clin Oncol doi: 10.1200/JCO.1998.16.4.1270 contributor: fullname: NA Heerema – volume: 16 start-page: 949 year: 2002 ident: 798_CR33 publication-title: Leukemia doi: 10.1038/sj.leu.2402491 contributor: fullname: NL Ramakers-van Woerden – volume: 94 start-page: 283 year: 1999 ident: 798_CR38 publication-title: Blood doi: 10.1182/blood.V94.1.283.413k23_283_290 contributor: fullname: JC Webb – volume: 63 start-page: 4882 year: 2003 ident: 798_CR16 publication-title: Cancer Res contributor: fullname: S Tsutsumi – volume: 12 start-page: 1344 year: 1998 ident: 798_CR1 publication-title: Leukemia doi: 10.1038/sj.leu.2401129 contributor: fullname: R Pieters – volume: 9 start-page: 147 year: 2009 ident: 798_CR42 publication-title: BMC Cancer doi: 10.1186/1471-2407-9-147 contributor: fullname: N Cerveira – volume: 37 start-page: 1289 year: 2005 ident: 798_CR20 publication-title: Nat Genet doi: 10.1038/ng1651 contributor: fullname: RA Dickins – volume: 132 start-page: 539 year: 2006 ident: 798_CR2 publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2005.05909.x contributor: fullname: RW Stam – volume: 114 start-page: 4169 year: 2009 ident: 798_CR37 publication-title: Blood doi: 10.1182/blood-2008-12-191619 contributor: fullname: A Kotani – volume: 20 start-page: 179 year: 2006 ident: 798_CR32 publication-title: Leukemia doi: 10.1038/sj.leu.2404031 contributor: fullname: RW Stam – volume: 7 start-page: 823 year: 2007 ident: 798_CR24 publication-title: Nat Rev Cancer doi: 10.1038/nrc2253 contributor: fullname: AV Krivtsov – volume: 137 start-page: 109 year: 2007 ident: 798_CR13 publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2007.06527.x contributor: fullname: AH Beesley – volume: 467 start-page: 343 year: 2010 ident: 798_CR46 publication-title: Nature doi: 10.1038/nature09350 contributor: fullname: H Liu – volume: 18 start-page: 521 year: 2004 ident: 798_CR8 publication-title: Leukemia doi: 10.1038/sj.leu.2403253 contributor: fullname: NL Ramakers-van Woerden – volume: 6 start-page: 59 year: 2005 ident: 798_CR19 publication-title: BMC Genomics doi: 10.1186/1471-2164-6-59 contributor: fullname: PB Dallas – volume: 100 start-page: 1926 year: 2009 ident: 798_CR11 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605072 contributor: fullname: AH Beesley – volume-title: Apoptosis year: 2009 ident: 798_CR10 contributor: fullname: C Ploner – volume: 48 start-page: 2083 year: 2007 ident: 798_CR43 publication-title: Leuk Lymphoma doi: 10.1080/10428190701606826 contributor: fullname: M Kubicka – volume: 324 start-page: 1029 year: 2009 ident: 798_CR30 publication-title: Science doi: 10.1126/science.1160809 contributor: fullname: MG Vander Heiden – volume: 66 start-page: 4591 year: 2006 ident: 798_CR34 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-3826 contributor: fullname: ER Lawlor – volume: 140 start-page: 716 year: 2008 ident: 798_CR6 publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2007.06966.x contributor: fullname: MJ Henderson – volume: 17 start-page: 700 year: 2003 ident: 798_CR9 publication-title: Leukemia doi: 10.1038/sj.leu.2402883 contributor: fullname: CH Pui – volume: 100 start-page: 7853 year: 2003 ident: 798_CR36 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1132115100 contributor: fullname: T Rozovskaia – volume: 18 start-page: 7387 year: 1999 ident: 798_CR40 publication-title: Oncogene doi: 10.1038/sj.onc.1203145 contributor: fullname: S Takeuchi – volume: 21 start-page: 2385 year: 2007 ident: 798_CR29 publication-title: Genes Dev doi: 10.1101/gad.1574507 contributor: fullname: H Liu – volume: 87 start-page: 10 year: 2008 ident: 798_CR23 publication-title: Int J Hematol doi: 10.1007/s12185-007-0009-8 contributor: fullname: Y Dou |
SSID | ssj0017874 |
Score | 2.0231152 |
Snippet | Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor prognosis and... Abstract Background Rearrangement of the mixed-lineage leukemia gene ( MLL ) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated... Background Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor... Abstract Background: Rearrangement of the mixed-lineage leukemia gene (MLL ) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated... BACKGROUNDRearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor... BACKGROUND: Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with poor... Abstract Background Rearrangement of the mixed-lineage leukemia gene (MLL) is found in 80% of infant acute lymphoblastic leukemia (ALL) and is associated with... |
SourceID | doaj pubmedcentral biomedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 284 |
SubjectTerms | Acute lymphocytic leukemia Apoptosis Cancer Cancer therapies Cell cycle Cell Line, Tumor Colleges & universities Corticosteroids Deoxyribonucleic acid DNA DNA damage DNA Damage - genetics Drug resistance Drug Resistance, Neoplasm - genetics Drug therapy Experiments Gene expression Genes Genetic aspects Glucocorticoids - pharmacology Health aspects Humans Lymphocytes - drug effects Medical research Myeloid-Lymphoid Leukemia Protein - genetics Myeloid-Lymphoid Leukemia Protein - metabolism Oligonucleotide Array Sequence Analysis Pediatrics Physiological aspects Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism Proteins Reverse Transcriptase Polymerase Chain Reaction Risk factors RNA Interference |
SummonAdditionalLinks | – databaseName: BiomedCentral dbid: RBZ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagCMQFQXmFFuQDElwsYsdxbHHaAlVB3Z6oVHGxbMdWV2yTqps99ND_3nEeS90iLkh7iifWJvP6Jp4HQu-t9NRWpSHOFJ5wKUpivaCEhTp4CN6CsrHeeX4kDo75j5Py5E-z6Fsn-FSKT5RXgvBSgV4SsKX30QMWO6rEwHzv1-bAAOSuP0CeiMcuPn_Z4FZl-zJxSH3f_rvW-YZ7SlMnb_ii_afoyQgi8Wzg-jN0zzfb6OEwVvJyGz2ajwfmz9HV92kICW4DBlxck_jRFc8PD3Hb4D5hHeJP2Kdd1HgVs9mHcRLYNDW-GBJoPe5a_PVoRmpzBuYHLxp8Pk34wMatO4-XlyAVrQUoDlvhpV__9mcL8wId73_7-eWAjBMXiAVk0hHjjQxSiLyQ4PpdXriiZgWvKVXWlDmnyseCJxOCcAVAQVBoZaSkvA40VEEWL9FW0zb-NcKOygBSWrLcMF5Sp6wzAB4Yr60C1CUz9Dlhgz4fumvo2O86XQHV05GJOjJRKw1MzNDHiWmbG_twRoq7pHuRqcn-_QUQMj2qpzbOg1Rar8ABcBHnkYCdC4EFAw5emipDH6JI6Kj18J-cGYsX4Flj_yw9i1U2kpclUO4mlKCtLlnemYRKj9ZipVUEUoDbVIbwZjXeGBPgGt-uV1rmABRj3fM_SASP7QQVvNpXg5BunpnlqoK4tshQlYhv8lLSlWZx2jcbZ0pWShZv_otdO-hxn3UBPyZ30VZ3sfZvAcx19l2vxtf1ZEeB priority: 500 providerName: BioMedCentral – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJRAXRMtraUE-IMHFapw4zlg9LY-qoG5PVOrNsh1brNgmVTd76IH_zjiP1ZpKcEHaUzyx1p7P9jfxPAh5Z8FzW5WGOVN4JkCWzHrJWR7q4NF4C8rGeOfFhTy7FN-uyqudUl_RJ2xIDzxM3LFxHuWtV7g0hYyVIhCBIeTB4NYLZogjz9RkTI33BwjD_j5ZVJKJUsGY1IeDPN4-Y4rl8Geg-yo5n_o0_vc3653TKvWk3DmaTp-SJyOnpPNhLPvkgW8OyMOhyuTdAXm0GO_Pn5FfX6eaJLQNFGlyzeI3WLo4P6dtQ3v_dTRHsZ92WdN1dG4fqktQ09T0dvCn9bRr6eeLOavNNe5GdNnQm6ngBzVu03m6ukOQtBaZOXZFV37z018vzXNyefrl-6czNhZgYBaJSseMNxBAyqwAZAIuK1xR54WoOVfWlJngysf4JxOCdAUyQ1zfygBwUQceqgDFC7LXtI1_RajjEBC0ZZ6ZXJTcKesMcolc1FYhCYMZOUnUoG-GZBs6pr9OW3Al6qhEHZWolUYlzsiHSWnbF3vrBuR90Y9RqUn__QMEnR5Bp_8Fuhl5HyGh4yaA_8mZMZYBxxrTael5DLoBUZYoeZRI4uJ1SfPhBCo9bh5rrSKvQhqnZoRuW-OL0R-u8e1mrSFD3hjDoP8iIkXMLqhwal8OIN2OOc9UhWZuMSNVAt9kUtKWZvmjzz2eK6gUFK__xywekse9Lwb-cjgie93txr9BitfZt_1q_g3K9k8n priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFLegE2gXBOOrbCAfkOBiLXYcxxYH1MGmgdYKISbtZtmOPSq6pOvHYQf-d54Tt1qYNKmn2rGSvN977-f4fSD03kpPbVkY4kzuCZeiINYLSliogofNW1A25juPJ-L0nH-_KC5SbM4yhVVubGJrqKvGxW_khyo6G_Bt6vP8msSmUfFwNXXQeIh2GGwUsgHaOTqe_Pi5PUYANPJUz4dKcUh5KQgvFKg4YfL_HPdZzzW1Ffzv2ulbjqofRHnLK508RU8SncSjTv7P0ANf76FHXYPJmz30eJyOzp-jv9827UhwEzAw5IrEz694fHaGmxq3oeuwE4V1mmmFlzGuvWssgU1d4UUXSuvxqsFfJyNSmSswRHha4_mm1wc2br3yeHYD-GgskHJYCs_8-o-_mpoX6Pzk-NeXU5J6LxALHGVFjDcySCGyXAIJcFnu8orlvKJUWVNknCofU59MCMLlQApBtZWRkvIq0FAGmb9Eg7qp_WuEHZUB8FqwzDBeUKesM0AjGK-sAv4lh-hTTwx63tXZ0LHydX8EAKGjEHUUolYahDhEHzdC217YbmykuDv1KAq1t377R7O41ElRtXEe8Gm9AlfARexMAhYvBBYMuHppyiH6ECGho_7DPTmT0hjgWWMlLT2K-TaSFwXMPOjNBL11veH9Dah0shtLvUX5EOHtaLwwhsLVvlkvtcyAMsYM6HumCB4LCyp4ta86kG6fmWWqhB1uPkRlD769l9Ifqae_27LjTMlSyfzNvfe9j3bb-Ar4MXmABqvF2r8F2ray75Jy_gP24EWN priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCMQFQXmFFuQDElwMseM4thBCy6MqqNsTK_Vm2Y4NK7ZJ2c1K7IH_zjiPbUOrSjmtHSv2fGN_s54HQi-t9NQWuSHOZJ5wKXJivaCEhTJ4MN6CsjHeeXosDmf820l-cl4OqF_A1ZWmXawnNVsu3vz5vfkACv--VXgp3lJeCMJzBZpLYLe9iW4xDmZ69OPj51cKgMz2inno3Of5uWKA_2LfF6Mjq83sf3n_vnCAjZ0rL5xWB_fRvZ5m4kmHiwfohq920e2u8ORmF92Z9lfqD9Hfr0OZElwHDMy5JPFvWTw9OsJ1hVuXdrBQYZx6XuJV9HfvCk5gU5V42bnYetzU-PPxhJTmFDYoPK_w2VADBBu3bjxebAA3tQWyDkPhhV__8qdz8wjNDr58_3RI-poMxAJ3aYjxRgYpRJpJIAcuzVxWsoyXlCpr8pRT5WNIlAlBuAzIIqi8MlJSXgYaiiCzx2inqiv_FGFHZQAc5yw1jOfUKesM0AvGS6uAl8kEvRuJQZ91-Td0zIg9bgHl1FGIOgpRKw1CTNDrQWjbF1uDR4rLXT9GoY7Gb3-olz90r8DaOA-4tV7BEcFFrFgCO2EILBigANIUCXoVIaEjUuGbnOnDG2CuMcOWnsQ4HMnzHHruj3qCPrtR894AKj2og1aRagGzUwnC29b4YnSRq3y9XmmZApWMkdHXdBE8JhxUsLRPOpBu58xSVYDlmyWoGMF3tCjjlmr-s01HzpQslMyeXT-tPXS3dbyAh8l9tNMs1_458LnGvmj19B_W60is priority: 102 providerName: Scholars Portal |
Title | Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20979663 https://www.proquest.com/docview/902249109 https://search.proquest.com/docview/808461142 https://search.proquest.com/docview/864955998 http://dx.doi.org/10.1186/1476-4598-9-284 https://pubmed.ncbi.nlm.nih.gov/PMC2987983 https://doaj.org/article/acef9bbe9153460680225ff2fa3628a7 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLe2IRAXBANG2ah8QIKL1zhxEluc2rFpVGs1DSZVXCzbsSGiTap-HHbgf-c5H9XCJA5IVSrFH0ryfs_v5-R9IPRec0t1GitiVGQJ40lMtE0oCV3mLGzenNA-3nkyTS5v2XgWz_ZQ3MbCVE77RuenxXxxWuQ_K9_K5cIMWj-xwfXkLISNsuDRYB_tA0DbLXrz6QAQyJocPpQnA8rShLBYgFoTWIp98t9ApEDyo79C3Ocdy1Ql8H-4TN-zU10fyntG6eI5etawSTysr_oF2rPFIXpc15e8O0RPJs2X85fo95e2GgkuHQaCnBH_9hVPrq5wWeDKcx02ojBPmWd47d3a67oSWBUZXtWetBZvSvx5OiSZWsA6hPMCL9tSH1iZ7cbi-R3Ao9TAyWEqPLfbX3aRq1fo9uL829klaUovEA0UZUOUVdzxJAkiDhzABJGJsjBiGaVCqzhgVFgf-aScS0wEnBA0WyjOKcscdanj0Wt0UJSFfYOwodwBXOMwUCGLqRHaKGARIcu0APrFe-hTRwxyWafZkD7xdbcFdFB6eUovTykkyLOHPrZC2w2s9jU8edh15IXamb86Ua5-yAZeUhkL8NRWgCVgiS9MAguec6FTYOm5Snvog4eE9OoP12RUE8UA9-oTacmhD7fhLI6h50mnJ6it6TQft6CSzbKxlsIzKiBwoofwrtUP9J5whS23a8kDYIw-APofXRLm8woKeLRHNUh399xiv4fSDnw7D6XbAkpYZR1vlO7tf488Rk8r1wv4hfwEHWxWW_sOGN1G90GPZ2kfPRoOx1_H8D86n17f9Kv3I3CcMA7Hm9H3fqXpfwAiyFSl |
link.rule.ids | 108,230,315,730,783,787,867,888,2109,2228,12068,21400,24330,24949,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806,76146,76147 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagiMcFQXktLeADElysxonj2OKAlke1hd09tVJvlu3YZcU2WfZx6IH_zkySXTVUqpRT7FhJ5puZz8k8CHnvVOCuyC3zNgtMKJkzFyRnaSxjgM1b1A7znSdTOToTP87z8y42Z9WFVW5tYmOoy9rjN_Ijjc4GfJv-vPjDsGkU_lztOmjcJfewDBc2MCjOd_stDlgUXTUfruQRF4VkIteg4CxV_2e4z3uOqanff9NKX3NT_RDKaz7p-Al53JFJOmyl_5TcCdU-ud-2l7zaJw8m3Y_zZ-TvybYZCa0jBX5cMvz4SifjMa0r2gSuwz4U1qlnJV1hVHvbVoLaqqTLNpA20HVNv02HrLSXYIborKKLbacPav1mHej8CtBRO6DksBSdh83vcDmzz8nZ8ffTryPWdV5gDhjKmtlgVVRSJpkCCuCTzGdlmomSc-1sngiuAyY-2Rilz4ASgmJrqxQXZeSxiCp7QfaqugqvCPVcRUBrniY2FTn32nkLJCIVpdPAvtSAfOqJwSzaKhsG6173RwAOBoVoUIhGGxDigHzcCm13YbOtUfLm1C8o1N76zYl6eWE6NTXWB0CnCxocgZDYlwTsXYxptODolS0G5ANCwqD2wz152yUxwLNiHS0zxGwbJfIcZh72ZoLW-t7wwRZUprMaK7PD-IDQ3SheiIFwVag3K6MSIIyY_3zLFCmwrKCGV_uyBenumdNEF7C_zQak6MG391L6I9XsV1N0PNWq0Cp7fet9vyMPR6eTsRmfTH8ekEdNpAUcqToke-vlJrwBArd2bxs1_QcHyEcY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLdgiIkLH-OrbIAPSHBJGyeOY4tT2ag2aKsdmDRxsWzHhmptUrXpYUj87zzno2o2icOknOpnK05-7_n3mveB0AfNLdFpogKjYhtQzpJAW0aCyGXOgvPmhPb5zpMpO72g3y6Ty51WX1XQvtGzfj5f9PPZ7yq2crkwgzZObHA-OY7AURY8HiwzN7iPHoDOhqx11JsPCIBD2lTyIZwNCE1ZQBMByh2AQfYlgEORAtWPbyS6zzvnU1XG_7ax3jmtupGUO0fT6An62W6qjki56m9K3Td_btR7vNOun6LHDWHFw1rkGbpn8wP0sG5heX2A9ifNx_nn6O9Z2_AEFw4DB88C_wcvnozHuMhxFRwPvi6sU8wyvPaR83XrCqzyDK_qYF2LywKfTIdBphZg6vAsx8u2mwhWZlNaPL8GBBYaaD8shed2c2UXM_UCXYy-_jg-DZruDoEGFlQGyiruOGNhzIFmmDA2cRbFNCNEaJWElAjrk6uUc8zEQDvBeAjFOaGZIy51PH6J9vIit68RNoQ70IgkClVEE2KENgqISkQzLYDh8R763HnHcllX8pC-tnZ3BNRcerBIDxYpJIClhz61iNhOrFwnzm6LfvGI6axf_VCsfsnmXUplLGiAtgIOG8p87xOwqc5FTgGZ4CrtoY8eb9JbGLgno5pECdirr9Ulhz6jh9MkAcmjjiRYBtMZPmwRKxvLtJbCkzbgiKKH8HbUT_TBdrktNmvJQyClPsf6PyKM-tKFAh7tq1oDtntuFauH0o5udB5KdwQQXxU2bxD-5s4z36P985ORHJ9Nvx-iR1WgB1wRP0J75Wpj3wJ_LPW7ylL8A5pocj4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+wild-type+MLL+on+glucocorticoid+sensitivity+and+response+to+DNA-damage+in+pediatric+acute+lymphoblastic+leukemia&rft.jtitle=Molecular+cancer&rft.au=Beesley%2C+Alex+H&rft.au=Rampellini%2C+Janelle+L&rft.au=Palmer%2C+Misty-Lee&rft.au=Heng%2C+Jasmin+YS&rft.date=2010-10-28&rft.pub=BioMed+Central+Ltd&rft.issn=1476-4598&rft.eissn=1476-4598&rft.volume=9&rft.spage=284&rft_id=info:doi/10.1186%2F1476-4598-9-284&rft.externalDocID=A242484557 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-4598&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-4598&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-4598&client=summon |